- OUR VISION
-
Treatment-focused medical paradigm is now shifting to preventive medicine that emphasizes disease prevention before it occurs.
Along with these changes, interest in individual and national health care is also focused on prevention and early diagnosis of diseases.
In case of Prostate cancer, the incidence rate is on the rapid rise in Korea and one-third of prostate cancer patients are still diagnosed in an incurable stage.
PROCAGEN therefore aims to increase the early diagnosis rate of prostate cancer by using the results of prostate cancer risk prediction and ultimately contribute to bringing a better world where men can live a healthy life without prostate cancer.
PROCAGEN will be a leading company in the industry of big data and AI technology-based disease prediction and diagnosis.